Xenex Raises $25 Million to Develop More Bug-Fighting Robots

Xenex Disinfection Services, a San Antonio, TX, robotics company that specializes in cleaning hospitals by zapping microscopic pathogens, is using a new $25 million financing round to expand its U.S. sales force and fund product development.

The company’s ultraviolet disinfection technology, which Xconomy’s Angela Shah detailed in 2013, destroys viruses, bacteria, mold, fungus, and bacterial spores that can cause infections, the company said in a statement. Xenex’s products are used in more than 250 hospitals and other facilities nationally, and it could aid the more than 700 hospitals that received fines related to infections, CEO Morris Miller said in the statement.

Brandon Point Industries Limited joined as an investor in the $25 million round, and was joined by existing investors Battery Ventures, Targeted Technology Fund II and RK Ventures. The latter three participated in a $11.3 million funding in 2013.

Author: David Holley

David is the national correspondent at Xconomy. He has spent most of his career covering business of every kind, from breweries in Oregon to investment banks in New York. A native of the Pacific Northwest, David started his career reporting at weekly and daily newspapers, covering murder trials, city council meetings, the expanding startup tech industry in the region, and everything between. He left the West Coast to pursue business journalism in New York, first writing about biotech and then private equity at The Deal. After a stint at Bloomberg News writing about high-yield bonds and leveraged loans, David relocated from New York to Austin, TX. He graduated from Portland State University.